24.20
-0.43(-1.75%)
Currency In USD
| Previous Close | 24.63 |
| Open | 24.67 |
| Day High | 25.08 |
| Day Low | 23.81 |
| 52-Week High | 40.37 |
| 52-Week Low | 4.3 |
| Volume | 619,227 |
| Average Volume | 2.76M |
| Market Cap | 1.11B |
| PE | -13.83 |
| EPS | -1.75 |
| Moving Average 50 Days | 24.67 |
| Moving Average 200 Days | 12.22 |
| Change | -0.43 |
If you invested $1000 in Capricor Therapeutics, Inc. (CAPR) 10 years ago, it would be worth $952.76 as of February 12, 2026 at a share price of $24.2. Whereas If you bought $1000 worth of Capricor Therapeutics, Inc. (CAPR) shares 5 years ago, it would be worth $3,239.63 as of February 12, 2026 at a share price of $24.2.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA Following FDA Review of HOPE-3 Topline Data
GlobeNewswire Inc.
Jan 20, 2026 2:15 PM GMT
FDA has requested the HOPE-3 clinical study report (CSR) as part of the BLA review processCompany expects to submit updates to the BLA in February 2026 to support continued FDA review SAN DIEGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeut
Caprock Provides Update on Drilling and Announces Expansion of Drill Program at Its Destiny Gold Project
Newsfile
Dec 17, 2025 1:00 PM GMT
Toronto, Ontario--(Newsfile Corp. - December 17, 2025) - Caprock Mining Corp. (CSE: CAPR) ("Caprock" or the "Company") is pleased to provide an update on its ongoing drilling activities, and announces an expansion of its drill program to test deep-se
Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar Highlighting Positive Phase 3 HOPE-3 Topline Results in Duchenne Muscular Dystrophy
GlobeNewswire Inc.
Dec 16, 2025 9:05 PM GMT
– Webinar to be held Wednesday, December 17, 2025, at 1:00 p.m. ET – SAN DIEGO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics, tod